Literature DB >> 4055037

Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies.

M E Lucero, C C Kuo.   

Abstract

Seventeen monoclonal antibodies (MAs) were tested. Five of seven serovar-specific MAs from five different serovars and two of five subspecies-specific MAs showed neutralizing activity as well as serovar specificity. No species- or genus-specific MAs showed neutralizing activity. No neutralization occurred without complement. Results indicate neutralization was serovar specific and complement dependent.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4055037      PMCID： PMC262000          DOI： 10.1128/iai.50.2.595-597.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Neutralization of Chlamydia trachomatis in cell culture.

Authors:  L V Howard
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  The titration of trachoma and inclusion blennorrhoea viruses in cell cultures.

Authors:  G FURNESS; D M GRAHAM; P REEVE
Journal:  J Gen Microbiol       Date:  1960-12

Review 3.  The antigenic structure of proteins: a reappraisal.

Authors:  D C Benjamin; J A Berzofsky; I J East; F R Gurd; C Hannum; S J Leach; E Margoliash; J G Michael; A Miller; E M Prager
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

4.  Activation of mouse complement by different classes of mouse antibody.

Authors:  G G Klaus; M B Pepys; K Kitajima; B A Askonas
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

5.  Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies.

Authors:  M R Tam; W E Stamm; H H Handsfield; R Stephens; C C Kuo; K K Holmes; K Ditzenberger; M Krieger; R C Nowinski
Journal:  N Engl J Med       Date:  1984-05-03       Impact factor: 91.245

6.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

7.  Localization of distinct surface antigens on Chlamydia trachomatis HAR-13 by immune electron microscopy with monoclonal antibodies.

Authors:  R B Clark; I Nachamkin; P F Schatzki; H P Dalton
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay.

Authors:  R C Barnes; S P Wang; C C Kuo; W E Stamm
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

9.  Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein.

Authors:  H D Caldwell; L J Perry
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

10.  In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein.

Authors:  R Peeling; I W Maclean; R C Brunham
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441
View more
  33 in total

1.  Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Authors:  Z D Cui; D Tristram; L J LaScolea; T Kwiatkowski; S Kopti; P L Ogra
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 2.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

3.  Ultrastructural study of Chlamydia trachomatis surface antigens by immunogold staining with monoclonal antibodies.

Authors:  C C Kuo; E Y Chi
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

4.  An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells.

Authors:  C Kuo; N Takahashi; A F Swanson; Y Ozeki; S Hakomori
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein.

Authors:  D Vanrompay; E Cox; G Volckaert; B Goddeeris
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 6.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.

Authors:  Z Qu; X Cheng; L M de la Maza; E M Peterson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Characterization of the humoral response induced by a synthetic peptide of the major outer membrane protein of Chlamydia trachomatis serovar B.

Authors:  A Villeneuve; L Brossay; G Paradis; J Hébert
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Authors:  J U Igietseme; P B Wyrick; D Goyeau; R G Rank
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic.

Authors:  A D Murdin; H Su; D S Manning; M H Klein; M J Parnell; H D Caldwell
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.